News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CancerVax Corporation (CNVX) Announces Results Of Phase 3 Clinical Trials Of Canvaxin(TM) In Patients With Stage III And Stage IV Melanoma


3/24/2006 11:56:21 AM

CancerVax Corporation (NASDAQ: CNVX) announced that data from its Phase 3 clinical trials of Canvaxin™ in the treatment of patients with advanced-stage melanoma will be presented today at the Society for Surgical Oncology's Annual Meeting in San Diego, California.

Read at BioSpace.com


comments powered by Disqus
   
Melanoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES